These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11993202)

  • 1. Acute occlusion of coronary artery bypass graft with nonionic contrast medium.
    Tomizawa Y; Endo M; Nishida H; Koyanagi H
    Jpn J Thorac Cardiovasc Surg; 2002 Apr; 50(4):181-3. PubMed ID: 11993202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty.
    Schräder R; Esch I; Ensslen R; Fach WA; Merle H; Scherer D; Sievert H; Spies HF; Zeplin HE
    J Am Coll Cardiol; 1999 Feb; 33(2):395-402. PubMed ID: 9973019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of contrast media on thrombus formation during coronary angioplasty.
    Gasperetti CM; Feldman MD; Burwell LR; Angello DA; Haugh KH; Owen RM; Powers ER
    J Am Coll Cardiol; 1991 Aug; 18(2):443-50. PubMed ID: 1856412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ionic and nonionic low osmolar contrast media in relation to thrombotic complications of angioplasty in patients with unstable angina.
    Malekianpour M; Bonan R; Lespérance J; Gosselin G; Hudon G; Doucet S; Laurier J; Duval D
    Am Heart J; 1998 Jun; 135(6 Pt 1):1067-75. PubMed ID: 9630113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catastrophic thrombus development despite systemic heparinization during coronary angioplasty: possible relationship to nonionic contrast.
    Doorey AJ; Stillabower ME; Gale N; Goldenberg EM
    Clin Cardiol; 1992 Feb; 15(2):117-20. PubMed ID: 1737403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serious acute coronary thrombosis associated with heparin-induced thrombocytopenia in off-pump coronary artery bypass grafting.
    Matsue H; Masai T; Yoshikawa Y; Kawamura M
    Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):188-90. PubMed ID: 20504888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic complications in coronary angiography associated with the use of nonionic contrast medium.
    Grollman JH; Liu CK; Astone RA; Lurie MD
    Cathet Cardiovasc Diagn; 1988; 14(3):159-64. PubMed ID: 3383237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy.
    Danzi GB; Capuano C; Sesana M; Predolini S; Baglini R
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):477-82. PubMed ID: 14624424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular fibrillation during coronary angiography: reduced incidence with nonionic contrast media.
    Missri J; Jeresaty RM
    Cathet Cardiovasc Diagn; 1990 Jan; 19(1):4-7. PubMed ID: 2306765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary angioscopic comparison of thrombus formation during percutaneous coronary angioplasty with ionic and nonionic low osmolality contrast media in unstable angina.
    Qureshi NR; den Heijer P; Crijns HJ
    Am J Cardiol; 1997 Sep; 80(6):700-4. PubMed ID: 9315572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed-type hypersensitivity to a nonionic, radiopaque contrast medium.
    Courvoisier S; Bircher AJ
    Allergy; 1998 Dec; 53(12):1221-4. PubMed ID: 9930602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recurrent parotid enlargement following coronary angiography].
    Wilhelmi M; Gasser S
    Praxis (Bern 1994); 2008 May; 97(10):569-70. PubMed ID: 18595374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography.
    Hardiek KJ; Katholi RE; Robbs RS; Katholi CE
    J Diabetes Complications; 2008; 22(3):171-7. PubMed ID: 18413220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early hemodynamic cardiovascular reactions to nonionic low-osmolar contrast media in coronary angiography].
    Wink K
    Rontgenblatter; 1988 Sep; 41(9):384-8. PubMed ID: 3175478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast controversy: more to it than meets the eye.
    Brinker JA
    J Am Coll Cardiol; 1991 Aug; 18(2):451-3. PubMed ID: 1856413
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty.
    Grines CL; Schreiber TL; Savas V; Jones DE; Zidar FJ; Gangadharan V; Brodsky M; Levin R; Safian R; Puchrowicz-Ochocki S; Castellani MD; O'Neill WW
    J Am Coll Cardiol; 1996 May; 27(6):1381-6. PubMed ID: 8626947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous angioscopy of saphenous vein coronary bypass grafts.
    White CJ; Ramee SR; Collins TJ; Mesa JE; Jain A
    J Am Coll Cardiol; 1993 Apr; 21(5):1181-5. PubMed ID: 8459074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Less iodine injected for the same diagnostic performances: comparison of two low-osmolar contrast agents (iobitridol 350 and iopamidol 370) in coronary angiography and ventriculography: a randomized double-blind clinical study.
    Velázquez MT; Albarrán A; Hernández F; García Tejada J; Zueco J; Andreu J; De la Torre JM; Figueroa A; Sainz F; Tascón J
    Acta Cardiol; 2010 Aug; 65(4):387-94. PubMed ID: 20821930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of thrombogenicity among nonionic radiocontrast agents.
    Georgakis A; Ener RA; Jin J; Kunapuli S; Fiss D; Leech SH; Wolf NM; Van Decker WA
    J Invasive Cardiol; 2008 Jul; 20(7):349-53. PubMed ID: 18599893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
    Bertrand ME; Esplugas E; Piessens J; Rasch W
    Circulation; 2000 Jan; 101(2):131-6. PubMed ID: 10637198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.